Joseph Lewis, 10% Owner, Director at Odonate Therapeutics, Inc. (ODT), bought 225,000 shares at $14.89 ($3.4M) on 2020-09-04, disclosed to the SEC on 2020-09-09.
Open-market purchase of $3.4M ODT by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.89 | 125,100 | $1.9M | 55.2% |
| 2 | $14.69 | 18,800 | $276K | 8.2% |
| 3 | $15.20 | 81,100 | $1.2M | 36.6% |
| Total | $14.99 avg | 225,000 | $3.4M | 100% |
| Filing → |
| MRTX | SELL | 2020-10-30 | $154.5M | — | Filing → |
| ODT | BUY | 2020-09-30 | $2.9M | — | Filing → |
| INSG | BUY | 2018-12-20 | $29.3M | — | Filing → |